Optimization of cardiac metabolism in heart failure - Wikidata - wikimedia - TriplyDB

Optimization of cardiac metabolism in heart failure

Optimization of cardiac metabolism in heart failure

http://www.wikidata.org/entity/Q27023021

about

Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure Regulation of cardiac autophagy by insulin-like growth factor 1 Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis Regulation of pyruvate metabolism and human disease Metabolomic profiling analysis reveals chamber-dependent metabolite patterns in the mouse heart.Transition from metabolic adaptation to maladaptation of the heart in obesity: role of apelin 1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients.Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice.Emerging role of liver X receptors in cardiac pathophysiology and heart failure.Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis.Transient decrease in serum potassium level during ischemic attack of acute coronary syndrome: paradoxical contribution of plasma glucose level and glycohemoglobin Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.Measuring changes in substrate utilization in the myocardium in response to fasting using hyperpolarized [1-(13)C]butyrate and [1-(13)C]pyruvate.Epigenetic regulation in heart failure.Normal cardiac function in mice with supraphysiological cardiac creatine levels Taxonomy of segmental myocardial systolic dysfunction.Insulin resistance and heart failure: molecular mechanisms Regulation of cellular gas exchange, oxygen sensing, and metabolic control.Metabolic remodeling in chronic heart failure.Trimetazidine in Practice: Review of the Clinical and Experimental Evidence.Glucose oxidation positively regulates glucose uptake and improves cardiac function recovery after myocardial reperfusion.Sucrose Nonfermenting-Related Kinase Enzyme-Mediated Rho-Associated Kinase Signaling is Responsible for Cardiac Function.Dynamic adaptation of myocardial proteome during heart failure development The thermogenic actions of natriuretic peptide in brown adipocytes: The direct measurement of the intracellular temperature using a fluorescent thermoprobe.Rapid induction of aldosterone synthesis in cultured neonatal rat cardiomyocytes under high glucose conditions.IGF-1 and NT-proBNP in a black and white population: The SABPA study.Cardiac Insulin Signaling Regulates Glycolysis Through Phosphofructokinase 2 Content and Activity.Genetic deletion of aquaporin-1 results in microcardia and low blood pressure in mouse with intact nitric oxide-dependent relaxation, but enhanced prostanoids-dependent relaxation.Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.Identification of homocysteine-suppressive mitochondrial ETC complex genes and tissue expression profile - Novel hypothesis establishment.Polymer Functionalization of Isolated Mitochondria for Cellular Transplantation and Metabolic Phenotype Alteration.A Similar Metabolic Profile Between the Failing Myocardium and Tumor Could Provide Alternative Therapeutic Targets in Chemotherapy-Induced Cardiotoxicity.The Cardio- and Neuroprotective Effects of Corvitin and 2-Oxoglutarate in Rats with Pituitrin-Isoproterenol-Induced Myocardial Damage Metabolic Modulation of Cardiac Metabolism in Heart Failure

P2860

Q26745026-4DF13682-9A6B-4C1A-8D03-3D9D7D6B4E17 Q27025162-1E566B41-AD65-40BC-AEB9-A8A9E6399906 Q33740348-B7604FC9-C5EA-4DAE-865E-93511FD2FB5C Q33764544-140FCE46-6A24-4F03-8737-B074B3CCB9C2 Q34781444-D1DDC00C-155A-4C07-BD45-2CE3254D5DCC Q35080694-14677A79-A461-488F-8E63-294A0022090D Q35088508-31E3330F-9408-42E6-9344-2463D7392351 Q35677381-FD0D0D25-E212-427B-B3FC-69CAE1633594 Q36322805-B7F479EA-6D4D-4320-80A9-F3DA3C74B392 Q36353539-C0C5EF68-D648-4128-893E-1611C5481637 Q36578795-A20FF11D-7703-4D8E-93BC-77042425D3AE Q36592548-5D993A27-9699-47AB-9E44-86FB299341E6 Q36674142-52478433-5593-4068-8EF7-EEED0E05F60D Q36797382-1FACA32E-DFA9-4247-87EE-6F24B3A989AD Q36875198-B95E29FA-3CDD-4D0A-8157-7404C16CCEC0 Q37114038-61478E9F-CEA4-44C0-B8ED-D3BD35CB2B22 Q37575876-CCB580A1-71C0-4FC6-9F35-3CCCC9A4FCF3 Q37738593-57B065C5-92F7-4851-A755-450F7EBC7D6F Q38045550-92D6236A-0424-42A4-92DC-DA8E58CC8178 Q38125147-D7CC3DDC-75D3-492F-B2C8-34E99F399F72 Q38125159-2161841A-D7BD-43E3-959F-CFE3101E0503 Q38371888-251EBB50-457A-4BB4-BA34-30F426AADC6D Q38888754-DCB4BCC0-B2CE-4D9E-8046-83D5D323E00D Q39250080-B686CAEC-78FF-4FF2-81DA-EDED81305021 Q42369675-F980293E-D8E3-43DB-982E-4587B0C49D2A Q42374834-CC38D0D4-36F7-4720-A767-5DEFA69C1C6A Q43537312-955FDC49-3800-4077-8E0C-94283526D674 Q46808848-2D18114A-AE7F-4BAF-9776-DF8CE6E7ED5F Q47332502-F4668A8E-E978-4956-BF02-91515BA54C56 Q47966984-6401269C-E645-4800-A9BE-13B648AC525F Q49247394-819DF998-5628-41C0-B771-C8802686D800 Q52313611-9EDA0F36-98AA-4B22-AAC9-9CF8C608B9C5 Q52624291-5DAC73F0-3194-4691-A795-002321268B21 Q55313684-C668DB3A-0DDE-4DCB-B03A-D554A92683E5 Q58766836-40641290-06C4-492A-82BA-A992C5C9B408 Q58804689-73DE18F4-5A23-4A62-B36B-C0B57FE733DD

P2860

Optimization of cardiac metabolism in heart failure

http://www.wikidata.org/entity/Q27023021

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Optimization of cardiac metabolism in heart failure

@ast

Optimization of cardiac metabolism in heart failure

@en

Optimization of cardiac metabolism in heart failure

@nl

type

label

Optimization of cardiac metabolism in heart failure

@ast

Optimization of cardiac metabolism in heart failure

@en

Optimization of cardiac metabolism in heart failure

@nl

prefLabel

Optimization of cardiac metabolism in heart failure

@ast

Optimization of cardiac metabolism in heart failure

@en

Optimization of cardiac metabolism in heart failure

@nl

P1433

Q27023021-2AC6FA91-206F-4349-9CDB-1F231823D842

P1476

Q27023021-15B1901C-ADD5-419D-BFD7-986E088CEC95

P2093

Q27023021-352DAFE4-A2C7-444C-AABE-6C659875CEB2

Q27023021-58B59EEF-3400-4582-BF0A-5C1576FCCEAF

Q27023021-CC12F12E-E93B-419D-A6B8-99ACACA7A476

Q27023021-E65361AD-F959-410A-908D-F18521068FB2

Q27023021-FD670231-88CC-4978-9228-B77FBD8F344E

P275

Q27023021-EB7B6ACE-7AD6-4C10-9DD8-8AF38069D36A

P2860

Q27023021-0181B29C-0EFD-4BBB-9B28-51551C79A75D

Q27023021-03EDF97D-AA6F-4728-9A5B-76A046B37CD1

Q27023021-0CD19827-3BB2-4B44-B746-C4426E069498

Q27023021-0DB64CBB-B86A-4FC8-8635-D3ADF9456B2F

Q27023021-128E6FF7-7DA9-4909-BA1A-0C365A3EC644

Q27023021-1B35F191-6D0C-4833-9A27-7867379BEA39

Q27023021-1CF1B73E-0AD8-44E7-8025-73E0FBF68D2D

Q27023021-20BA7C88-D824-4D3E-BCAF-F65EBF59D4AB

Q27023021-22B13BCB-CA84-4798-9B79-AF928574E998

Q27023021-263E489F-4495-4A80-A18E-C5A17B4A64A1

P304

Q27023021-F5D00490-6C61-4394-952F-970042F7592F

P31

Q27023021-180739BD-ACDD-4A7E-8A5C-7974C9026AF5

Q27023021-828EBD74-BAC6-4248-8763-E5A0C4032512

P3181

Q27023021-CEDBCD4B-D174-4334-B145-CBE03513D25B

P356

Q27023021-A702D4B7-D5E7-4935-ABFD-B4E2F911CB3F

P407

Q27023021-011D1EDE-EB96-4FC7-8549-D3AA38E48121

P433

Q27023021-1A22BC47-BEEB-4FCB-8A2B-892108CAC447

P478

Q27023021-DE68F7A8-7BF1-4B2F-8277-970B314A360C

P5008

Q27023021-68A7937C-8734-4D29-B993-81C3CB15C291

P577

Q27023021-2D265900-C648-4A61-9165-D564651D24AE

Q27023021-6F14C787-5BFE-4B49-9D0E-64CF22C6E70E

P5875

Q27023021-1C6BFFBA-66C6-4420-9157-666AC4EED3CA

P698

Q27023021-F3692A7C-0CD8-452C-AC5F-BB507550F131

P921

Q27023021-119EB6BF-9C93-47FF-BEE7-1AE0723B570A

Q27023021-29ED3666-43C1-4FA3-830C-0A4C6EE044B1

Q27023021-60D50C0A-0F52-4AB8-860A-FBC901201FA3

Q27023021-FAEF7A38-977E-4A89-A9EF-A13ECB5E079F

P932

Q27023021-B8796155-2FED-493E-A963-D623160654FC

P3181

P356

138161211798357773

P1433

Current Pharmaceutical Design

P1476

Optimization of cardiac metabolism in heart failure

@en

P2093

Lopaschuk GD

http://www.w3.org/2001/XMLSchema#string

Mochizuki S

http://www.w3.org/2001/XMLSchema#string

Nagoshi T

http://www.w3.org/2001/XMLSchema#string

Rosano GM

http://www.w3.org/2001/XMLSchema#string

Yoshimura M

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1

Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?

Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy.

Aldosterone production is activated in failing ventricle in humans.

An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.

Aldosterone status associated with insulin resistance in patients with heart failure--data from the ALOFT study.

P304

3846-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1811201

http://www.w3.org/2001/XMLSchema#string

P356

10.2174/138161211798357773

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51657038

http://www.w3.org/2001/XMLSchema#string

P698

21933140

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

human musculoskeletal system

P932

3271354

http://www.w3.org/2001/XMLSchema#string